Frequency, risk factors, and impact on mortality of arterial thromboembolism in patients with cancer
Cancer is a well-known risk factor for the occurrence of venous thromboembolism. In contrast, little research has been...
ARCHIVE
Lessons from the CATCH study: beware of the risk of bleeding in neoplastic patients treated for VTE
The results of an interesting secondary analysis of the CATCH study were published recently and they are useful for a...
The present and the future of the SSC Subcommittee Hemostasis and Malignancies
ISTH 2018 – Marc Carrier, Cihan Ay What is the SSC Subcommittee for Hemostasis and Malignacy up to? Marc Carrier,...
Rapping about new anticoagulants for CAT at ICTHIC 2018
Rapping about new anticoagulants for CAT at ICTHIC 2018 Cancer patients are four or five times as likely to develop...
Nicola Mutch at ICTHIC 2018
We met with Nicola Mutch, president elect of the ISTH SCC, during the 9th ICTHIC in Bergamo. She explains where her...
Anticoagulant treatment in patients with thrombocytopenia and cancer-associated thrombosis
One of the most complex situations in the treatment of cancer-associated thrombosis is represented by oncological...
Arterial thromboembolism can also be the first clinical manifestation of a neoplasm
Several studies showed that venous thrombosis can be the first clinical manifestation of an occult neoplasm. For this...
Are new anticoagulants a safe and reasonable alternative to low molecular weight heparins?
Dr. Buller and Dr. Noble comment on their DOACs face-off that took place during the 9th ICTHIC...
The management of cancer patients with hemostatic disorders (thrombosis and/or bleeding) faces many clinical challenges
The management of cancer patients with hemostatic disorders (thrombosis and/or bleeding) faces many clinical...
An interview with Raffaella Giavazzi
Raffaella Giavazzi during her 5th Simon Karpatkin Memorial Lecture at the 9th ICTHIC in...